A. John Rush
Affiliations: | Psychiatry | University of Texas Southwestern Medical Center, Dallas, TX, United States |
Google:
"A. Rush"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rothman B, Slomkowski M, Speier A, et al. (2024) Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study. Jmir Research Protocols. 13: e56960 |
| Milaneschi Y, Montanari S, Jansen R, et al. (2024) Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort. Research Square |
| Chan KMY, Low LT, Wong JG, et al. (2024) Healthcare resource utilisation and suicidal ideation amongst adolescents in the US with posttraumatic stress disorder, major depressive disorder, and substance use disorders using electronic health records. Journal of Affective Disorders |
| Sackeim HA, Aaronson ST, Bunker MT, et al. (2024) Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2). Journal of Psychiatric Research. 176: 325-337 |
| Jansen R, Milaneschi Y, Schranner D, et al. (2024) The metabolome-wide signature of major depressive disorder. Molecular Psychiatry |
| Bhattacharyya S, MahmoudianDehkordi S, Sniatynski MJ, et al. (2024) Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder. Medrxiv : the Preprint Server For Health Sciences |
| Conway CR, Aaronson ST, Sackeim HA, et al. (2024) Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report. Brain Stimulation |
| Palmer EOC, Ker S, Rentería ME, et al. (2024) Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder. Neuropsychiatric Disease and Treatment. 20: 671-687 |
| Montanari S, Jansen R, Schranner D, et al. (2024) Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort. Medrxiv : the Preprint Server For Health Sciences |
| Vreijling SR, Chin Fatt CR, Williams LM, et al. (2023) Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials. The British Journal of Psychiatry : the Journal of Mental Science. 1-9 |